[1. Revuz J, Valeyrie-Allanore L. Drug Reactions. In: Bolognia J, Jorizzo J, Rapini RP, editors. Dermatology. London: Mosby- Elsevier; 2008.]Search in Google Scholar
[2. Bachot N, Roujeau JC. Diff erential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 2003;4(8):561-72.10.2165/00128071-200304080-00006]Search in Google Scholar
[3. Shear NH, Knowles SR, Shapiro L. Cutaneous reactions to drugs. In: Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill; 2003. p. 355-62.]Search in Google Scholar
[4. Mockenhaupt M. Epidemiology of cutaneous adverse drug reactions. Chem Immunol Allergy 2012;97:1-17.10.1159/000335612]Search in Google Scholar
[5. Fiszenson-Albala F, Auzerif V, Mahe E, Farinotti R, Durand- Stocco C, Crickx B, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003;149:1018-22.10.1111/j.1365-2133.2003.05584.x]Search in Google Scholar
[6. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis and management. Lancet 2000;356:1255-9.10.1016/S0140-6736(00)02799-9]Search in Google Scholar
[7. Crowson AN, Brown TJ, Magro CM. progress in the understanding of the pathology and pathogenesis of cutaneous drug eruptions: implications for management. Am J ClinDermatol 2003;4:407-28.10.2165/00128071-200304060-00005]Search in Google Scholar
[8. Barbaud AM, Bene MC, Schmutz JL. Role of delayed cellular hypersensitivity and adhesion molecules in amoxicillin-induced morbilliform rashes. Arch Dermatol 1997;133:481-6.10.1001/archderm.1997.03890400081011]Search in Google Scholar
[9. Romano A, Quaratino D, Di Fonso M, Papa G, Venuti A, Gasbarrini G. A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins. J Allergy Clin Immunol 1999; 103:1186-90.10.1016/S0091-6749(99)70197-1]Search in Google Scholar
[10. Greaves MA, Hussein SH. Drug-induced urticaria and angioedema: pathomechanisms and frequencies in a developing country and in developed countries. Int Arch Allergy Immunol 2002;128:1-7.10.1159/00005799712037395]Search in Google Scholar
[11. Caimmi S, Caimmi D, Bernardini R, Caffarelli C, Crisafulli G, Pingitore G, et al. Perioperative anaphylaxis: epidemiology. Int J Immunopathol Pharmacol 2011;24(Suppl 3):S21-6.10.1177/03946320110240S30422014922]Search in Google Scholar
[12. Barbaud A, Goncalo M, Bruznzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001; 45:321-8.10.1034/j.1600-0536.2001.450601.x11846746]Search in Google Scholar
[13. Csernok E, Lamprecht P, Gross WL. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Curr Opin Rheumatol 2010;22(1):43-8.10.1097/BOR.0b013e328332353819770659]Search in Google Scholar
[14. Sehgal VN, Srivastava G, Sharma S, Sehgal S, Verma P. Lichenoid tissue reaction/interface dermatitis: recognition, classification, etiology, and clinicopathological overtones. Indian J Dermatol Venereol Leprol 2011;77(4):418-29.10.4103/0378-6323.8238921727689]Search in Google Scholar
[15. Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: a literature review. Am J Med 2011;124(7):588-97.10.1016/j.amjmed.2011.01.01721592453]Search in Google Scholar
[16. Walsh SA, Creamer D. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol 2011;36(1):6-11.10.1111/j.1365-2230.2010.03967.x21143513]Search in Google Scholar
[17. Hazin R, Ibrahimi OA, Hazin MI, Kimyai-Asadi A. Stevens Johnson syndrome: Pathogenesis, diagnosis, and management. Ann Med 2008;40:129-38.10.1080/0785389070175366418293143]Search in Google Scholar
[18. Mijušković Ž, Šofranac D, Kandolf-Sekulović L, Zečević R. Stevens-Johnsonov sindrom uzrokovan lamotriginom: prikaz slučaja [Steven-Johnson syndrome induced by lamotrigen: a case report]. In: Abstract Book of the 15th Belgrade Dermatology Days; 2010 November 12 - 13; Belgrade (Serbia). Beograd: Srpsko lekarsko društvo [Serbian medical society]; 2010. p. 54, PS-15. (Serbian).]Search in Google Scholar
[19. Downey A, Jackson C, Harun N, Cooper A. Toxic epidermal necrolysis: review of pathogenesis and management. J Am Acad Dermatol 2012;66(6):995-1003.10.1016/j.jaad.2011.09.02922169256]Search in Google Scholar
[20. Mladenović T, Kostić K, Kozarski J, Panišić M, Begović V, Kandolf-Sekulović L, et al. In: Abstract Book of the 15th Belgrade Dermatology Days; 2010 November 12 - 13; Belgrade (Serbia). Beograd: Srpsko lekarsko društvo [Serbian medical society]; 2010. p. 53, PS-14. (Serbian).]Search in Google Scholar
[21. Fernando SL. Acute generalised exanthematous pustulosis. Australas J Dermatol 2012;53(2):87-92.10.1111/j.1440-0960.2011.00845.x22571555]Search in Google Scholar
[22. Thyssen JP, Maibach HI. Drug-elicited systemic allergic (contact) dermatitis--update and possible pathomechanisms. Contact Dermatitis 2008; 59:195-202.10.1111/j.1600-0536.2008.01367.x18844694]Search in Google Scholar
[23. Khaled A, Sellami A, Fazaa B, Kharfi M, Zeglaoui F, Kamoun MR. Acquired erythroderma in adults: a clinical and prognostic study. J Eur Acad Dermatol Venereol 2010; 24(7):781-8.10.1111/j.1468-3083.2009.03526.x20028449]Search in Google Scholar
[24. Potthoff K, Hofheinz R, Hassel JC, Volkenandt M, Lordick F, Hartmann JT,Karthaus M, Riess H, Lipp HP, Hauschild A, Trarbach T, Wollenberg A.Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion. Ann Oncol. 2011; 22(3):524-35.10.1093/annonc/mdq38720709812]Search in Google Scholar
[25. Atzori L, Pinna AL, Ferreli C, Aste N. Pityriasis rosealike adverse reaction:review of the literature and experience of an Italian drug-surveillance center. Dermatol Online J 2006; 12(1):1. 10.5070/D380D8301D]Search in Google Scholar